Call Us Now

+91 9606900005 / 04

For Enquiry

PIB Summaries 20 May 2022


  1. State of Inequality in India Report
  2. New development bank
  3. Tuberculosis

State of Inequality in India Report

Focus: GS II- Polity and Governance

Why in News?

Recently, the ‘State of Inequality in India’ Report was released by the Economic Advisory Council to the Prime Minister (EAC-PM).

About  State of Inequality in India Report

  • The report gathers information on inequities in health, education, household factors, and the labour market. Inequity in these areas makes the population more vulnerable and leads to a spiral of multidimensional poverty.
  • The research broadens the narrative on inequality by providing a complete analysis that shapes the country’s ecosystem of diverse deprivations, which has a direct impact on the population’s well-being and overall growth.
  • The data for the report comes from the Periodic Labour Force Survey (PLFS), the National Family and Health Survey (NFHS), and the United Information System for Education Plus.

Click Here To Read More: State of Inequality in India Report

New Development Bank

Focus: GS II- International Relations

Why in news?

Union Minister of Finance & Corporate Affairs and India’s Governor for the New Development Bank (NDB), Smt. Nirmala Sitharaman chaired the 7th Annual Meeting of Board of Governors of NDB through video-conference in New Delhi


  • The meeting was also attended by Governors/Alternate Governors of Brazil, China, Russia, South Africa and the newly joined members Bangladesh and United Arab Emirates (UAE).
  • This year’s theme for the Annual Meeting was “NDB: Optimising Development Impact”, which is particularly important and relevant in the current global economic scenario.
  • The Finance Minister underscored the importance of multilateralism and the spirit of global cooperation for economic recovery. 

Click Here To Read More: New Development Bank.


Focus: GS II- Health

Why in News?

Union Minister for Health and Family Welfare addressed the 35th Board meeting of the Stop TB Partnership through video-conference,

About Tuberculosis

  • TB remains the world’s deadliest infectious killer.
  • Each day, over 4000 people lose their lives to TB and close to 30,000 people fall ill with this preventable and curable disease
  • TB is caused by bacteria (Mycobacterium tuberculosis) that most often affect the lungs.
  • Transmission: TB is spread from person to person through the air. When people with TB cough, sneeze or spit, they propel the TB germs into the air.
  • Symptoms: Cough with sputum and blood at times, chest pains, weakness, weight loss, fever and night sweats.
  • Treatment: TB is a treatable and curable disease. It is treated with a standard 6 month course of 4 antimicrobial drugs that are provided with information, supervision and support to the patient by a health worker or trained volunteer.
  • Anti-TB medicines have been used for decades and strains that are resistant to 1 or more of the medicines have been documented in every country surveyed.
  • Multidrug-resistant tuberculosis (MDR-TB) is a form of TB caused by bacteria that do not respond to isoniazid and rifampicin, the 2 most powerful, first-line anti-TB drugs. MDR-TB is treatable and curable by using second-line drugs.
  • Extensively drug-resistant TB (XDR-TB) is a more serious form of MDR-TB caused by bacteria that do not respond to the most effective second-line anti-TB drugs, often leaving patients without any further treatment options.

July 2024